Improvement in relative survival of patients with vasculitis: Study of 101 cases compared to the general population

International Journal of Immunopathology and Pharmacology

Volumn 21, Issue 3, 2008, Pages 631-642

  Stratta, Piero ^a   Marcuccio, C ^b   Campo, A ^c   Sandri, L ^d   Messuerotti, A ^b   Colla, L ^b   Rosso, S ^e   Mazzucco, G ^b   Mariani, L ^b   Ciccone, G ^b  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c S Lazzaro Hospital   (Italy)

^d Pinerolo Hospital

^e Department of Biomedical Science and Human Oncology

Author keywords

Micropolyarteritis; Pauci immune extracapillary glomerulonephritis; Relative survival renal vascular diseases; Vasculitis; Wegener

Indexed keywords

AZATHIOPRINE; CREATININE; CYCLOPHOSPHAMIDE; METHYLPREDNISOLONE; STEROID;

ADULT; ANGIOGRAPHY; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE EXACERBATION; DISEASE SEVERITY; EARLY DIAGNOSIS; FEMALE; GLOMERULONEPHRITIS; HEMODIALYSIS; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MALE; MICROSCOPIC POLYANGIITIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PLASMAPHERESIS; POLYARTERITIS; PREDICTION; PRIORITY JOURNAL; RENAL VASCULITIS; RENOVASCULAR DISEASE; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SEROLOGY; SURVIVAL RATE; WEGENER GRANULOMATOSIS;

EID: 53749098336     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463200802100317     Document Type: Article

References (35)

1. Jennette JC, Falk RJ. Small vessel vasculitis N Engl J Med 1997; 337:1512-1523.
2. Booth AD, Pusey CD, Jayne DR. Renal vasculitis-an update in 2004. Nephrol Dial Transplant 2004; 19: 1964-1968.
3. Morgan MD, Harper L, Williams J, Savage C. Anti-neutrophil cytoplasm-associated glomerulonephritis. J Am Soc Nephrol 2006; 17:1224-1234.
4. Pusey CD. The continuing challenge of anti-neutrophil cytoplasm antibody-associated systemic vasculitis and glomerulonephritis. J Am Soc Nephrol 2006; 15:1221-3.
5. Tidman M, Olander R, Svalander C, Danielsson D. Patients hospitalized because of small vessel vasculitides with renal involvement in the period 1975-95: organ involvement, anti-neutrophil cytoplasmic antibodies patterns, seasonal attack rates and fluctuation of annual frequencies. J Intern Med 1998; 244:133-1341.
6. de Lind van Wijngaarden RA, Hauer HA, et al. Clinical and histologic determinants of renal outcome in ANCA-associated vasculitis: A prospective analysis of 100 patients with severe renal involvement. J Am Soc Nephrol 2006; 17:2264-74.
7. Hauer HA, Bajema IM, Van Houwelingen HC, Ferrario F, Noel LH, Waldherr R, Jayne DR, Rasmussen N, Bruijn JA, Hagen EC; European Vasculitis Study Group (EUVAS). Determinants of outcome in ANCA-associated glomerulonephritis: a prospective clinico-histopathological analysis of 96 patients. Kidney Int 2002; 62:1732-42.
8. Bourgarit A, Le Tournelin P, Pagnoux C, Cohen P, Mahr A, Le Guern V, Mouthon L, Guillevin L; French Vasculitis Study Group. Deaths occurring during the first year after treatment onset for polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: a retrospective analysis of causes and factors predictive of mortality based on 595 patients. Medicine (Baltimore) 2005; 84:323-330.
9. de Groot K, Adu D, Savage CO; EUVAS (European vasculitis study group). The value of pulse cyclophosphamide in ANCA-associated vasculitis: meta-analysis and critical review. Nephrol Dial Transplant 2001; 16:2018-2027.
10. de Groot K, Rasmussen N, Bacon PA, Tervaert JW, Feighery C, Gregorini G, Gross WL, Luqmani R, Jayne DR. Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum 2005; 52: 2461-2469.
11. Joy MS, Hogan SL, Jennette JC, Falk RJ, Nachman PH. A pilot study using mycophenolate mofetil in relapsing or resistant ANCA small vessel vasculitis. Nephrol Dial Transplant 2005; 20:2725-32.
12. Hunder GG, Arend WP, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of vasculitis. Introduction. Arthritis Rheum 1990; 33:1065-7.
13. Lightfoot RW Jr, Michel BA, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosa. Arthritis Rheum 1990; 33:1088-93.
14. Leavitt RY, Fauci AS, Bloch DA, Michel BA, et al. The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum 1990; 33:1101-7.
15. Jennette JC, Falk RJ, Andrassy K, et al. Nomenclature of systemic vasculitides. Proposal of an International Consensus Conference. Arthritis Rheum 1994; 37: 187-92.
16. Hakulinen T. Cancer survival corrected for heterogeneity in patient withdrawal. Biometrics 1982; 38:933-942.
17. Hakulinen T, Tenkanen L, Abeywickrama K, Paivarinta L. Testing equality of relative survival patterns based on aggregated data. Biometrics 1987; 43:313-325.
18. Hogan SL, Falk RJ, Chin H, Cai J, Jennette CE, Jennette JC, Nachman PH. Predictors of relapse and treatment resistance in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis. Ann Intern Med 2005; 143:621-31.
19. Vergunst CE, van Gutp E, Hagen EC, et al. EC/BCR Project for ANCA-Assay Standardisation. An index for renal outcome in ANCA-associated glomerulonephritis. Am J Kidney Dis 2003; 41:532-8.
20. Harper L, Savage CO. ANCA-associated renal vasculitis at the end of the twentieth century--a disease of older patients. Rheumatology (Oxford) 2005; 44:495-501.
21. Hogan SL, Falk RJ, Nachman PH, Jennette JC. Various forms of life in antineutrophil cytoplasmic antibody-associated vasculitis. Ann Intern Med 2006; 144:377-3778.
22. Slot MC, Tervaert JWC, Frassen CFM, Stegeman CA. Renal survival and prognostic factors in patients with PR3-ANCA associated vasculitis with renal involvement Kidney Int 2003; 63:670-677.
23. Hauer HA, Bajema IM, Hagen EC,et al. Longterm renal injury in ANCA-associated vasculitis: an analysis of 31 patients with follow-up biopsies. Nephrol Dial Transplant 2002; 17:587-596.
24. Westman KWA, Selga D, Isberg PE, Bladstrom A, Olsson H. High pR3 ANCA measured by Capture ELISA method is associated with decreased patient survival in ANCA-associated vasculitis with renal involvement J Am Soc Nephrol 2003; 14: 2926-2933.
25. Ferrario F, Rastaldi MP. Histopathological atlas of renal diseases: ANCA-associated vasculitis (First part). J Nephrol 2005; 18:113-116.
26. Ferrario F, Rastaldi MP. Histopathological. atlas of renal diseases: ANCA-associated vasculitis (Second part). J Nephrol 2005; 18:217-220.
27. Falk RJ, Jennette JC. Thoughts about the classification of small vessel vasculitis. J Nephrol 2004; 17:S3-9.
28. Selga D, Mohammad A, Sturfelt G, Segelmark M. Polyarteritis nodosa when applying the Chapel Hill nomenclature--a descriptive study on ten patients. Rheumatology (Oxford) 2006; 45:1276-81.
29. Bruce IN, Bell AL. A comparison of two nomenclature systems for primary systemic vasculitis. Br J Rheumatol 1997; 36:453-8.
30. Cohen BA, Clarck WE Pauci-immune renal vasculitis: natural history, prognostic factors, and impact of therapy Am J Kidney Dis 2000; 36:914-924.
31. Booth Ad, Almond NK, Bums A, Ellis P, Gaskin G, Neild GH, Plaisance M, Pusey CD, Jayne DR; Pan-Thames Renal Research Group. Outcome of ANCA-associated renal vasculitis: a 5-year retrospective study Am J Kidney Dis 2003; 41:776-784.
32. Franssen CF, Stegeman CA, Oost-Kort WW, Kallenberg CG, Limburg PC, Tiebosch A, De Jong PE, Tervaert JW. Determinants of renal outcome in anti-myeloperoxidase-associated necrotizing crescentic glomerulonephritis. J Am Soc Nephrol 1998; 9:1915-23.
33. Scott DGI. Classification and treatment of systemic vasculitis. Br J Rheumatol 1988; 27:251-3.
34. Lie JT. Vasculitis; 1815-1991:classification and diagnostic specificity. J Rheumatol 1992; 19:83-9.
35. Jennette JC, Falk RJ. Nosology of primary vasculitis. Curr Opin Rheumatol 2007; 19:10-6.